Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

Share Price is delayed by 15 minutes
Get Live Data
36.60    0.10 (0.27%)
Bid:
36.50
Ask:
36.70
Spread: 0.20 (0.548%)
Market Cap: £26.87m
CAR Live PriceLast checked at - London Stock Exchange

Intraday Carclo Share Chart

Interim Management Statement

22 Jan 2014 07:00

RNS Number : 2240Y
Carclo plc
22 January 2014
 

22 January 2014

 

Carclo plc

("Carclo" or "the group")

 

Interim Management Statement

 

 

The board announces that the group's operating businesses, as expected, are enjoying stronger trading in the second half of the financial year but that lower than previously expected sales at Conductive Inkjet Technology ("CIT") will reduce the forecast profitability of CIT and hence of the group in the second half.

 

At CIT, sales of coated film in the second half are set to be ahead of the first half sales number, but below the board's previously disclosed estimated range. This is due to a slower than anticipated ramp up in production on the programs which are using XSense™ touch sensors. CIT's partner, Atmel Corporation ("Atmel"), recently announced its first production rollout for the HP Omni 10™ from its Colorado manufacturing site and Atmel continues to supply XSense™ for this program. Further programs are expected to progressively come on stream through the first half of 2014, benefitting from the superior capabilities of XSense™ (including narrow bezel capability) versus competitive offerings.

 

The market for XSense™ and other metal mesh solutions is growing rapidly as adoption begins to gain traction at the expense of ITO touch sensor solutions in this $5 billion market. At the same time we have seen competition in the market increase for all touch solutions, which is causing pricing pressure; while we expect developments in the touch sensor market to become clearer during 2014, this is likely to reduce coated film revenues and margins versus our previous estimates. The product capabilities of XSense™ are strong and we remain confident that it can gain a significant market share in this rapidly growing market.

 

The group's Technical Plastics, LED Technologies and Precision Engineering businesses are all performing in line with the board's expectations.

 

Technical Plastics has been awarded several new programs during the year and further significant program awards are anticipated within the next few months as this business enters a growth phase.

 

Within the LED Technologies Division we have secured new supercar lighting programs and anticipate further awards early in the next financial year which will drive significant growth in this specialist design and manufacturing business. Sales within the division's LED Optics are also growing well.

 

Precision Engineering continues to perform well and has maintained its prior year performance.

 

Progress at Carclo Diagnostic Solutions is as anticipated and we are on track to deliver working product prior to our year end for the previously disclosed trial project for an Acute Kidney Injury marker with EKF Diagnostics Systems plc.

 

The group's balance sheet is strong and its funding remains secure. The board looks forward to sales and profits progression across the group in the coming financial year.

 

 

- ENDS -

 

 

Enquiries:

Carclo plc

01924 268040

Chris Malley, Chief Executive

Robert Brooksbank, Finance Director

Weber Shandwick Financial

020 7067 0700

Nick Oborne / Stephanie Badjonat

 

 

Notes to editors

 

Carclo plc is a technology group. It is a public company whose shares are quoted on the London Stock Exchange.

 

Carclo's strategy has been to develop new technologies and products to drive future growth. Its investment in CIT has led to the introduction of a new material for use in Capacitive Touch Screens. Further investment has been made in Carclo Diagnostic Solutions, where a novel Point-of-Care hardware platform has been developed.

 

Approximately three fifths of revenues are currently derived from the supply of fine tolerance, injection moulded plastic components, which are used in medical, optical and electronics products. This business, Carclo Technical Plastics, operates internationally in a fast growing and dynamic market underpinned by rapid technological development.

 

Approximately two fifths of revenues are derived from the supply of specialised precision LED based systems to the premium automotive industry, as well as key control systems for the aerospace industry.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSPGUPCGUPCUCP
Date   Source Headline
8th Jun 20107:00 amRNSFinal Results
24th May 201010:02 amRNSHolding(s) in Company
7th May 20104:49 pmRNSHolding(s) in Company
8th Apr 20107:00 amRNSPre-close trading statement
7th Apr 20103:30 pmRNSCDT and CIT demonstrate ITO-Free lighting panel
31st Mar 201010:19 amRNSHolding(s) in Company
22nd Mar 20104:27 pmRNSHolding(s) in Company
2nd Mar 20104:07 pmRNSHolding(s) in Company
25th Feb 20107:00 amRNSHolding(s) in Company
11th Feb 20107:00 amRNSInterim Management Statement
3rd Feb 20101:27 pmRNSHolding(s) in Company
2nd Feb 201012:41 pmRNSHolding(s) in Company
8th Jan 20109:26 amRNSHolding(s) in Company
4th Jan 20102:32 pmRNSTotal Voting Rights
4th Jan 20102:29 pmRNSHolding(s) in Company
4th Jan 20101:31 pmRNSHolding(s) in Company
24th Dec 200911:34 amRNSHolding(s) in Company
23rd Dec 20093:04 pmRNSHolding(s) in Company
22nd Dec 20092:06 pmRNSHolding(s) in Company
22nd Dec 20091:22 pmRNSHolding(s) in Company
17th Dec 20093:43 pmRNSPerformance Share Plan Award
16th Dec 20092:22 pmRNSDirector/PDMR Shareholding
16th Dec 200912:49 pmRNSDirector/PDMR Shareholding
16th Dec 20097:00 amRNSIssue of Equity
8th Dec 20097:00 amRNSAgreement with Atmel Corporation
24th Nov 20097:00 amRNSHalf Yearly Report
2nd Oct 20097:00 amRNSHalf Year Trading Update
4th Sep 20091:13 pmRNSResult of AGM
3rd Sep 20091:53 pmRNSHolding(s) in Company
13th Aug 20097:00 amRNSInterim Management Statement
12th Aug 20091:29 pmRNSHolding(s) in Company
30th Jul 20094:11 pmRNSHolding(s) in Company
1st Jul 20091:49 pmRNSHolding(s) in Company
24th Jun 20094:07 pmRNSDirector/PDMR Shareholding
9th Jun 20097:00 amRNSFinal Results
7th Apr 20097:00 amRNSPre-close trading update
4th Feb 20097:00 amRNSInterim Management Statement
21st Jan 20095:09 pmRNSDirectors's disclosure update
5th Dec 20082:13 pmRNSDirector/PDMR Shareholding
25th Nov 20087:00 amRNSInterim Results
25th Sep 20087:00 amRNSHalf year trading update
5th Sep 20089:39 amRNSResult of AGM
19th Aug 20087:00 amRNSInterim Management Statement
8th Aug 20083:01 pmRNSApproval for Xennia sale of C
16th Jun 20083:36 pmRNSDirector/PDMR Shareholding
10th Jun 20087:00 amRNSFinal Results
22nd May 200810:00 amRNSNotice of Results
8th Apr 20087:01 amRNSPre-Close Update
14th Feb 20083:30 pmRNSHolding(s) in Company
6th Feb 20087:00 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.